Clinical Trial Update: P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for P2Et extract evaluating symptomatic treatment in subjects with COVID-19 across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• P2Et extract

Snippet

Sponsor: Hospital Universitario San Ignacio | Conditions: COVID, Coronavirus Infection | Phase 2, Phase 3 | Status: UNKNOWN